Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study

We aimed to explore the medium- and long-term (≥12 weeks) effects of dapagliflozin on serum uric acid (SUA) level in patients with type 2 diabetes mellitus (T2DM) in the real world study and to explore the influencing factors of dapagliflozin on reducing SUA level. This observational, prospective co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shihan, Yuan, Tao, Song, Shuoning, Duo, Yanbei, Zhao, Tianyi, Gao, Junxiang, Fu, Yong, Dong, Yingyue, Zhao, Weigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861887/
https://www.ncbi.nlm.nih.gov/pubmed/36675682
http://dx.doi.org/10.3390/jpm13010021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861887/
https://www.ncbi.nlm.nih.gov/pubmed/36675682
http://dx.doi.org/10.3390/jpm13010021

Ejemplares similares